The Non Invasive screening test to detect genetic diseases of the fetus even before birth
Genesafe®: an innovative tool for experiencing pregnancy with more awareness.
The Non Invasive screening test to detect genetic diseases of the fetus even before birth
Genesafe®: an innovative tool for experiencing pregnancy with more awareness.
Prenatal Screening Tests
Prenatal Screening Tests are analyses performed during pregnancy to assess the health of the fetus.
These tests allow early detection of diseases associated with DNA variants.
Being informed is the first step to obtaining assistance in childbirth or to initiating, when possible, a course of treatment before or immediately after the birth of the child.
Genesafe®, the innovative non invasive prenatal test to detect inherited and de novo mutations associated with genetic disorders directly in the fetus, was born from the OrizzonteNascita project by Eurofins Genoma.
Genesafe® Genesafe® is a non invasive screening test to detect both hereditary and non-hereditary diseases by analyzing fetal DNA in maternal blood.
How is it performed?
The Genesafe® test is performed with a sample of maternal blood taken from the 10th week of pregnancy.
What does maternal blood contain?
During pregnancy, some fragments of fetal DNA circulate in maternal blood, in varying amounts depending on the week of pregnancy. This DNA is detectable from the 5th week of pregnancy; its concentration increases in subsequent weeks and disappears immediately after birth.
The amount of DNA from the 10th week of pregnancy is sufficient to ensure the high reliability of the test.
Genesafe®: for greater peace of mind during pregnancy.
Simple
A simple blood sample from the mother at the 10th week of pregnancy is required.
Safe
Eliminates the risks of abortion that are otherwise found with invasive prenatal diagnosis.
Fast
Results in just 10-15 working days.
Complete
Allows you to identify both mutations inherited from parents and mutations that occur for the first time in the fetus.
Three levels of investigation are included:
Inherited
Test that allows you to identify hereditary genetic diseases in the fetus.
De novo
This non-invasive prenatal examination allows you to analyze genetic diseases that are related to advanced paternal age.
Completed
Test that allows you to identify both hereditary and de novo genetic diseases in the fetus.
Who do we recommend Genesafe® to
It is suitable for any type of pregnancy
It is indicated in case of couples where the male partner is advanced in age (>40 years)
It is useful for pregnant women who want to reduce the risk of fetal genetic disease
It is recommended in case of contraindications to invasive investigations
It can be performed in case of single or twin pregnancies obtained either through natural conception or PMA technique
Genesafe® uses technology that guarantees:
- High sensitivity, as it detects alterations even with low amounts of fetal DNA
- Test reliability of over 99%
All non-invasive tests performed at Eurofins Genoma include:
- Free results control
- Free chorionic villus sampling or amniocentesis performed by gynecologists affiliated with Eurofins Genoma
- Refund in case of unobtainable result due to insufficient fetal DNA or inconclusive result